分化型甲状腺癌术后嗓音结局评估
基于SEER数据的横断面人群调查,2325例分化型甲状腺癌术后患者中,25.8%报告嗓音改变持续超过3个月,12.7%VHI-10评分异常,4.7%喉镜诊断声带运动障碍。年龄45-54岁、黑种人、亚洲人、胃食管反流病及侧颈清扫与VHI-10异常相关。
要点
- 术后12.7%患者VHI-10评分异常,提示嗓音障碍 prevalence 较高。
- 侧颈清扫者VHI-10异常风险增高(OR 1.99)。
- 胃食管反流病与嗓音异常相关(OR 1.67)。
核心结论
- VHI-10验证的嗓音异常高 prevalence 强调术后需提高对嗓音异常的警觉。
研究设计与样本
- 横断面、人群为基础调查,通过改良Dillman法发放问卷,链接SEER数据。
- 2325例2014-2015年接受分化型甲状腺癌手术且术前无嗓音异常的患者纳入分析。
主要发现
- 599例(25.8%)报告术后嗓音改变持续超过3个月。
- 272例(12.7%)VHI-10评分异常(>11)。
- 105例(4.7%)喉镜诊断声带运动障碍。
关键数值与推荐
- VHI-10评分>11定义为异常。
- 年龄45-54岁(参考≤44岁)OR 1.49(95%CI 1.05-2.11)。
- 黑种人OR 1.73(95%CI 1.14-2.62)。
- 亚洲人OR 1.66(95%CI 1.08-2.54)。
- 胃食管反流病OR 1.67(95%CI 1.15-2.43);侧颈清扫OR 1.99(95%CI 1.11-3.56)。
临床怎么用
- 术前风险获益讨论中应考虑嗓音异常风险。
- 计划手术范围及术后康复时需关注嗓音结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: An increasing number of surgeries are being performed for differentiated thyroid cancer (DTC). Long-term voice abnormalities are a known risk of thyroid surgery; however, few studies have used validated scales to quantify voice outcomes after surgery. OBJECTIVE: To identify the prevalence, severity, and factors associated with poor voice outcomes following surgery for DTC. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional, population-based survey was distributed via a modified Dillman method to 4185 eligible patients and linked to Surveillance, Epidemiology and End Results (SEER) data from SEER sites in Georgia and Los Angeles, California, from February 1, 2017, to October 31, 2018. Multivariable logistic regression and zero-inflated negative binomial analysis were performed to determine factors associated with abnormal voice. Participants included patients undergoing surgery for DTC between January 1, 2014, and December 31, 2015, excluding those with voice abnormalities before surgery. MAIN OUTCOMES AND MEASURES: Abnormal Voice Handicap Index (VHI-10) score, defined as greater than 11. The VHI-10 is designed to quantify 10 psychosocial consequences of voice disorders on a Likert scale (0, never; to 4, always). RESULTS: A total of 2632 patients (63%) responded to the survey and 2325 met the inclusion criteria. With data reported as unweighted number and weighted percentage, 1792 were women (77.4%); weighted mean (SD) age was 49.4 (14.4) years. Of these, 599 patients (25.8%) reported voice changes lasting more than 3 months following surgery, 272 patients (12.7%) were identified as having an abnormal VHI-10 score, and 105 patients (4.7%) reported vocal fold motion impairment diagnosed by laryngoscopy. In multivariable analysis, factors associated with an abnormal VHI-10 score included age 45 to 54 years (reference, ≤44 years; odds ratio [OR], 1.49; 95% CI, 1.05-2.11), black race (OR, 1.73; 95% CI, 1.14-2.62), Asian race (OR, 1.66; 95% CI, 1.08-2.54), gastroesophageal reflux disease (OR, 1.67; 95% CI, 1.15-2.43), and lateral neck dissection (OR, 1.99; 95% CI, 1.11-3.56). CONCLUSIONS AND RELEVANCE: A high prevalence of abnormal voice per validation with the VHI-10 emphasizes the need for heightened awareness of voice abnormalities following surgery and warrants consideration in the preoperative risk-benefit discussion, planned extent of surgery, and postoperative rehabilitation.
引用
- Kovatch KJ, Reyes-Gastelum D, Hughes DT, et al. Assessment of Voice Outcomes Following Surgery for Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31318375. doi:10.1001/jamaoto.2019.1737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。